AAAAAA

   
Results: 1-25 | 26-37 |
Results: 26-37/37
PHARMACEUTICAL ISSUES OF PACLITAXEL
Authors: KOELLER JM BURRIS HA DORR RT FINLEY RS GOLDSPIEL BR KUHN JG ROWINSKY EK
Citation: Jm. Koeller et al., PHARMACEUTICAL ISSUES OF PACLITAXEL, The Annals of pharmacotherapy, 28(5), 1994, pp. 190000005-190000036
PHASE-I CLINICAL-TRIAL OF GEMCITABINE GIVEN AS AN INTRAVENOUS BOLUS ON 5 CONSECUTIVE DAYS
Authors: OROURKE TJ BROWN TD HAVLIN K KUHN JG CRAIG JB BURRIS HA SATTERLEE WG TARASSOFF PG VONHOFF DD
Citation: Tj. Orourke et al., PHASE-I CLINICAL-TRIAL OF GEMCITABINE GIVEN AS AN INTRAVENOUS BOLUS ON 5 CONSECUTIVE DAYS, European journal of cancer, 30A(3), 1994, pp. 417-419
PHASE-I CLINICAL-TRIAL OF ORMAPLATIN (TETRAPLATIN, NSC-363812)
Authors: OROURKE TJ WEISS GR NEW P BURRIS HA RODRIGUEZ G ECKHARDT J HARDY J KUHN JG FIELDS S CLARK GM VONHOFF DD
Citation: Tj. Orourke et al., PHASE-I CLINICAL-TRIAL OF ORMAPLATIN (TETRAPLATIN, NSC-363812), Anti-cancer drugs, 5(5), 1994, pp. 520-526
PHARMACOKINETICS OF HYDROXYUREA IN NUDE-MICE
Authors: VANDENBERG CL MCGILL JR KUHN JG WALSH JT DELACRUZ PS DAVIDSON KK WAHL GM VONHOFF DD
Citation: Cl. Vandenberg et al., PHARMACOKINETICS OF HYDROXYUREA IN NUDE-MICE, Anti-cancer drugs, 5(5), 1994, pp. 573-578
PHASE-I AND PHARMACOKINETIC STUDIES OF TOPOTECAN ADMINISTERED AS A 72OR 120-H CONTINUOUS-INFUSION
Authors: BURRIS HA AWADA A KUHN JG ECKARDT JR COBB PW RINALDI DA FIELDS S SMITH L VONHOFF DD
Citation: Ha. Burris et al., PHASE-I AND PHARMACOKINETIC STUDIES OF TOPOTECAN ADMINISTERED AS A 72OR 120-H CONTINUOUS-INFUSION, Anti-cancer drugs, 5(4), 1994, pp. 394-402
PHASE-I TRIAL OF SULOFENUR (LY186641) GIVEN ORALLY ON A DAILY X 21 SCHEDULE
Authors: BROWN TD OROURKE TJ KUHN JG CRAIG JB HAVLIN K BURRIS HA CAGNOLA J HAMILTON JM GRINDEY GB SATTERLEE WG VONHOFF DD
Citation: Td. Brown et al., PHASE-I TRIAL OF SULOFENUR (LY186641) GIVEN ORALLY ON A DAILY X 21 SCHEDULE, Anti-cancer drugs, 5(2), 1994, pp. 151-159
PRECLINICAL AND PHASE-I TRIALS OF TOPOISOMERASE-I INHIBITORS
Authors: VONHOFF DD BURRIS HA ECKARDT J ROTHENBERG M FIELDS SM CHEN SF KUHN JG
Citation: Dd. Vonhoff et al., PRECLINICAL AND PHASE-I TRIALS OF TOPOISOMERASE-I INHIBITORS, Cancer chemotherapy and pharmacology, 34, 1994, pp. 190000041-190000045
A PHASE-I TRIAL OF TRIMETREXATE (NSC352122) ON A DAILY X 5 SCHEDULE IN PATIENTS WITH REFRACTORY ADULT LEUKEMIA
Authors: RODRIGUEZ G BROWN TD BALIS FM CRAIG JB DENHAM CA KUHN JG HAVLIN K VONHOFF DD
Citation: G. Rodriguez et al., A PHASE-I TRIAL OF TRIMETREXATE (NSC352122) ON A DAILY X 5 SCHEDULE IN PATIENTS WITH REFRACTORY ADULT LEUKEMIA, Anti-cancer drugs, 4(2), 1993, pp. 163-166
PHASE-I AND PHARMACOKINETIC TRIAL OF WEEKLY CPT-11
Authors: ROTHENBERG ML KUHN JG BURRIS HA NELSON J ECKARDT JR TRISTANMORALES M HILSENBECK SG WEISS GR SMITH LS RODRIGUEZ GI ROCK MK VONHOFF DD
Citation: Ml. Rothenberg et al., PHASE-I AND PHARMACOKINETIC TRIAL OF WEEKLY CPT-11, Journal of clinical oncology, 11(11), 1993, pp. 2194-2204
A PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF THE ORAL AND THE ORALINTRAVENOUS ADMINISTRATION OF MENOGARIL
Authors: WEISS GR BROWN TD KUHN JG VONHOFF DD EARHART RH ADAMS WJ BREWER JE HOSLEY JD KASUNIC DA
Citation: Gr. Weiss et al., A PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF THE ORAL AND THE ORALINTRAVENOUS ADMINISTRATION OF MENOGARIL, Investigational new drugs, 11(1), 1993, pp. 17-27
NUTRITIONAL PARAMETERS OBSERVED DURING 28-DAY INFUSION OF RECOMBINANTHUMAN TUMOR-NECROSIS-FACTOR-ALPHA
Authors: HARDIN TC KOELLER JM KUHN JG ROODMAN D VONHOFF DD
Citation: Tc. Hardin et al., NUTRITIONAL PARAMETERS OBSERVED DURING 28-DAY INFUSION OF RECOMBINANTHUMAN TUMOR-NECROSIS-FACTOR-ALPHA, JPEN. Journal of parenteral and enteral nutrition, 17(6), 1993, pp. 541-545
A RANDOMIZED PHASE-I TRIAL OF CHRONIC ORAL ETOPOSIDE WITH OR WITHOUT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH ADVANCED MALIGNANCIES
Authors: SHAFFER DW SMITH LS BURRIS HA CLARK GM ECKARDT JR FIELDS SM WEISS GR RINALDI DA BOWEN KJ KUHN JG VONHOFF DD
Citation: Dw. Shaffer et al., A RANDOMIZED PHASE-I TRIAL OF CHRONIC ORAL ETOPOSIDE WITH OR WITHOUT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH ADVANCED MALIGNANCIES, Cancer research, 53(24), 1993, pp. 5929-5933
Risultati: 1-25 | 26-37 |